Layered Polymeric Coatings for Controlled API Release
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Traditional drug-eluting polymeric coatings for medical devices face challenges in achieving controlled, sustained release of APIs, often leading to initial burst release and fluctuating therapeutic levels due to dependency on environmental stimuli and drug-polymer interactions, which can cause toxicity and reduce treatment efficacy.
Innovation Solution
A layered polymeric coating system comprising a primary coating with a water-soluble API in a hydrophilic polymer matrix and a top inert coating that facilitates non-Fickian diffusion, controlling API release through pressure-driven mechanisms, avoiding burst release and maintaining therapeutic levels.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Device complexity
If a single coating with drug embedded in polymer matrix is used, then the device structure is simple, but initial burst release occurs causing toxicity
Solution Approach 1:
The coating is divided into two distinct layers: a primary coating containing the drug-polymer matrix and a secondary top coating that controls release. This segmentation prevents burst release by separating the drug reservoir from the release interface, allowing controlled diffusion while maintaining structural simplicity through a straightforward layered architecture.
2Device complexity
If diffusion-driven release mechanism is used, then the release process is passive and simple, but controlled sustained release cannot be achieved
Solution Approach 1:
The release mechanism transitions from simple Fickian diffusion to non-Fickian diffusion by changing the polymer properties through water absorption. The hydrophilic polymer in the primary coating absorbs water and swells, altering the diffusion parameters and enabling controlled sustained release of the drug over time.
3Duration of action of moving object
If hydrophilic polymer matrix is used for water-soluble API, then sustained release is achieved, but polymer swelling creates uncontrolled pressure
Solution Approach 1:
The top coating acts as an intermediary layer between the swelling primary coating and the external environment. It allows controlled water ingress to sustain drug release while restraining excessive polymer swelling, thereby moderating the swelling pressure and preventing uncontrolled drug release.
4Ease of operation
If dependency on environmental stimuli is used to initiate release, then the release can be triggered, but release timing is unpredictable causing fluctuating therapeutic levels
Solution Approach 1:
The release mechanism is replaced from environmentally triggered (unpredictable) to water-driven diffusion (controlled). Water from the surrounding environment naturally penetrates the top coating and triggers gradual polymer swelling and drug release, eliminating dependency on unpredictable environmental stimuli and ensuring stable therapeutic levels.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The layered coating system achieves sustained, controlled release of APIs by non-Fickian diffusion, reducing burst release and fluctuation, enhancing treatment efficacy and patient compliance through precise control over release rates.
Implementation Method 1
deliver sustained release of the water-soluble API by non-Fickian diffusion across the top coating
Implementation Method 2
the primary coating may swell to create a pressure that drives the water-soluble API across the top coating
Implementation Method 3
in response to water crossing the top coating into the coating matrix, the water-soluble API may be released from the coating matrix
Implementation Method 4
the primary coating may swell to create a pressure that drives the water-soluble API across the top coating
Data Source
AI summary
A medical device may include a medical device surface, a primary coating on the medical device surface, and a top coating on the primary coating. The primary coating may include a coating matrix, and a water-soluble active pharmaceutical ingredient (API) within the coating matrix. The coating matrix may include a hydrophilic polymer, and the water-soluble API may be uniformly dispersed within the coating matrix. The top coating may include an inert polymer. In response to water crossing the top coating into the coating matrix, the water-soluble API may be released from the coating matrix and the primary coating may swell to create a pressure that drives the API across the top coating. A method of preparing layered polymeric coatings, including the top coating and the primary coating, on the medical device may include solvent-casting the medical device surface to form the primary coating and the top coating.